In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) closed at $8.19 in the last session, down -5.54% from day before closing price of $8.67. In other words, the price has decreased by -$5.54 from its previous closing price. On the day, 1.57 million shares were traded.
Ratios:
We take a closer look at AUPH’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 26.03. For the most recent quarter (mrq), Quick Ratio is recorded 4.17 and its Current Ratio is at 4.57. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.17.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Greenleaf Peter sold 195,593 shares for $8.00 per share. The transaction valued at 1,564,744 led to the insider holds 1,953,892 shares of the business.
Greenleaf Peter sold 164,947 shares of AUPH for $1,306,380 on Mar 04 ’25. The Chief Executive Officer now owns 1,788,945 shares after completing the transaction at $7.92 per share. On Mar 03 ’25, another insider, Keenan Greg, who serves as the Chief Medical Officer of the company, sold 12,239 shares for $8.00 each. As a result, the insider received 97,912 and left with 161,789 shares of the company.
Valuation Measures:
As of this moment, Aurinia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 212.18, and their Forward P/E ratio for the next fiscal year is 10.92. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.78 while its Price-to-Book (P/B) ratio in mrq is 3.06.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $10.67, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is 0.29%, while the 200-Day Moving Average is calculated to be 15.16%.
Shares Statistics:
A total of 140.88M shares are outstanding, with a floating share count of 123.53M. Insiders hold about 10.06% of the company’s shares, while institutions hold 42.22% stake in the company.
